-
COVID-19 trials and tribulations for treatments
expresspharma
May 24, 2021
COVID-19 has impelled the scientific community to research and develop new therapies to counter a serious viral pandemic. Since 2020, many old drugs repurposed as treatment for COVID-19 have been studied in clinical trials to assess efficacy and safety.
-
ISCR lauds clinical research stakeholders on International Clinical Trials Day
expresspharma
May 20, 2021
New models of clinical trials were effectively developed to ensure continuity of trials in a pandemic environment without compromising on patient safety, ethics and quality, sadi Dr Sanish Davis, President, ISCR.
-
Dr Sanish Davis is the new President of ISCR
expresspharma
April 02, 2021
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the appointment of Dr Sanish Davis as its President for the term 2021-23. Dr Davis takes over from Dr Chirag Trivedi, who was President ...
-
COVID-19 clinical trials have risen by 639 percent, says report
europeanpharmaceuticalreview
February 03, 2021
New findings have shown that there are currently over 4,000 clinical trials taking place investigating potential COVID-19 therapies.
-
Vaccine demonstrates efficacy against mutated polio strain in Phase II study
europeanpharmaceuticalreview
December 15, 2020
A clinical trial has shown that nOPV2 has the potential to overcome outbreaks caused by a mutated polio strain linked to the Sabin vaccine.
-
Pharmacovigilance during a pandemic
expresspharma
December 10, 2020
As coronavirus has become the new reality for every health worker and life science company to fight in the front, it is time to relook the approach being taken by the industry towards pharmacovigilance.
-
Team of 70 Ambassadors and High Commissioners visit Bharat Biotech, discuss COVAXIN
expresspharma
December 10, 2020
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
-
Trial to compare dexamethasone and baricitinib in hospitalised COVID-19 patients
europeanpharmaceuticalreview
November 27, 2020
The fourth iteration of the COVID-19 treatment trial will determine whether remdesivir plus baricitinib or dexamethasone, is more effective at promoting recovery from COVID-19.
-
Sputnik V COVID-19 vaccine over 90 percent effective, interim data shows
europeanpharmaceuticalreview
November 26, 2020
Phase III trial interim data has shown that Russia’s COVID-19 vaccine candidate, Sputnik V, is 91.4 percent effective.
-
Predicine and CR Medicon form strategic partnership to accelerate global Clinical Trials and Registration Approval
PharmaSources.com
November 16, 2020
On November 11, 2020, CR Medicon and Predicine jointly announced that it has entered into a global strategic partnership to assist biomarker-driven clinical trials and novel oncology therapeutics registration in US and China.